Company news
Genus Plc (LSE:GNS) news
Genus Plc news releases on 6ix. Latest, Feb 23, 2023: Chief Executive Officer Retirement
Press releases — page 2
Chief Executive Officer Retirement
February 23, 2023
Ruthin Site Visit
November 3, 2022
TR-1: Notification of Major Holdings
October 14, 2022
Appointment of Joint Corporate Broker
August 2, 2022
Director Declaration
March 31, 2022
Collaboration between PIC and Olymel LP in Canada
February 24, 2022
Disclosure of Rights Attached to Equity Shares
November 26, 2021
PIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
June 28, 2021
Capital Markets Event & PRRSv Programme Update
June 22, 2021
Application For Additional Listing
June 7, 2021
Board Changes
March 22, 2021
AGM Trading Update - Strong Performance Continues
November 25, 2020
NOTIFICATION OF MAJOR HOLDINGS
November 11, 2020
Application for Additional Listing
September 8, 2020
Directorate Appointment
June 29, 2020
Compliance with LR 9.2.6ER(1)
April 30, 2020
Appointment of Chief Financial Officer
November 20, 2019
AGM TRADING UPDATE
November 14, 2019
CORRECTION: Outcome of IntelliGen Litigation
September 11, 2019
Outcome of latest IntelliGen Litigation
September 11, 2019
OUTCOME IN LATEST INTELLIGEN LITIGATION
September 10, 2019
Appointment of Chief Executive Officer
August 22, 2019
Strategic porcine collaboration in China
May 16, 2019
Genus Chief Executive Transition
March 25, 2019
Result of placing to raise approximately £68m
December 7, 2018
Proposed placing to raise approximately £68m
December 6, 2018
Board Appointment
May 24, 2018
Additional Listing to Correct Discrepancy
November 17, 2017
Director/PDMR Shareholding - Replacement
September 21, 2017
US LITIGATION UPDATE
June 9, 2017
Update Regarding The Milk Pension Fund
June 1, 2017
SUCCESSFUL LEGAL OUTCOME FOR GENUS
April 3, 2017
Correction of Record Date
February 23, 2017
Acquisition and strategic partnership
February 23, 2017
AGM - Trading Update
November 17, 2016
Block Listing and Additional Listing
October 3, 2016
NON-EXECUTIVE DIRECTOR RETIREMENT
September 7, 2016
FINAL JURY DECISIONS IN US LITIGATION
August 15, 2016
FURTHER DECISIONS IN US LITIGATION
August 12, 2016
FIRST DECISIONS IN US ANTI-TRUST LITIGATION
August 11, 2016
Signs exclusive licence for tech. to combat BRD
July 27, 2016
Adoption of Financial Reporting Standard (FRS) 101
July 15, 2016
Second Price Monitoring Extn
June 17, 2016
Price Monitoring Extension
June 17, 2016
Exclusive Licence for Leading Gene Editing Tech
May 18, 2016
BOARD APPOINTMENT
March 4, 2016
INTERIM RESULTS
February 23, 2016
Blocklisting Interim Review
February 1, 2016
Tackles major pig disease with breakthrough tech
December 8, 2015
AGM - TRADING UPDATE
November 19, 2015